Evidence map›Paper›PMID 19116062›Full record

ArticleEmerging infectious diseases2009

Rotavirus genotype distribution after vaccine introduction, Rio de Janeiro, Brazil.

Filipe Anibal Carvalho-Costa, Irene Trigueiros Araújo, Rosane Maria Santos de Assis, Alexandre Madi Fialho, Carolina Maria Miranda de Assis Martins, Márcio Neves Bóia, José Paulo Gagliardi Leite

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Post-vaccine rotavirus genotype distribution in Nairobi County, Kenya.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Comparative genomic analysis of genogroup 1 (Wa-like) rotaviruses circulating in the USA, 2006-2009.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2014
    Article
  12. Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure?Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2014
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Filipe Anibal Carvalho-CostaLaboratory of Comparative Virology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Irene Trigueiros Araújo
Rosane Maria Santos de Assis
Alexandre Madi Fialho
Carolina Maria Miranda de Assis Martins
Márcio Neves Bóia
José Paulo Gagliardi Leite

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brazil introduced rotavirus vaccination in March 2006. We studied 133 rotavirus-positive fecal samples collected from February 2005 through December 2007. Genotype G2P[4] was found in 1.4% of samples in 2005, in 44% in 2006, and in 96% in 2007. Rotavirus detection rate decreased from 38% in 2005 to 24% in 2007 (p = 0.012).

Indexed as

Immunization ProgramsProgram EvaluationRotavirus InfectionsBrazilChild, PreschoolDiarrheaFecesGenotypeHospitalizationHumansInfantInfant, NewbornRotavirusRotavirus VaccinesVaccinationRotavirus Vaccines

Identifiers

PMID19116062
PMCPMC2660678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.